PFIZER INC Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost
PFIZER INC (PFE) had Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost of $9.00 billion as of 2014-06-29, per its 10-Q filed 2014-08-07.
Discontinued › Notes › Investments
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount · last filed 2014-08-07
- 2014-06-29: Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost $9.00B.
- 2014-03-30: Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost $8.50B.
- 2013-12-31: Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost $9.14B.
- 2012-12-31: Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost $1.46B.
| Period end | Debt Securities, Held-to-maturity, Maturity, without Single Maturity Date, Amortized Cost |
|---|---|
| 2014-06-29 | $9.00B 10-Q · filed 2014-08-07 |
| 2014-03-30 | $8.50B 10-Q · filed 2014-05-08 |
| 2013-12-31 | $9.14B 10-Q · filed 2014-08-07 |
| 2012-12-31 | $1.46B 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |